Gaëtan Devos

12PUBLICATIONS
29CO-AUTHORS
Cancer diagnosisCell physiologyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jan 09, 2026
Interreader agreement of intraprostatic prostate cancer detection, local extension and staging using [18F]PSMA-1007 PET and whole-mount radical prostatectomy specimens.

Niloefar Ahmadi Bidakhvidi, Elena Lara Jimenez, Hannes Leupe

|Nov 13, 2025
Relationship between [18F]PSMA-1007 PET parameters and biochemical recurrence-free survival in high-risk prostate cancer patients receiving neoadjuvant hormonal treatment.

Niloefar Ahmadi Bidakhvidi, Alexander Giesen, Gaëtan Devos

|Sep 13, 2024
Comparison of PSMA immunohistochemistry scoring systems to parametric [18F]PSMA-1007 PET/MRI in primary prostate cancer.

Niloefar Ahmadi Bidakhvidi, Thomas Gevaert, Maxim De Schepper

|Dec 26, 2022
Combining PSA and PET features to select candidates for salvage lymph node dissection in recurrent prostate cancer.

Carlo A Bravi, Axel Heidenreich, Nicola Fossati

|Sep 16, 2021
Neoadjuvant hormonal therapy before radical prostatectomy in high-risk prostate cancer.

Gaëtan Devos, Wout Devlies, Gert De Meerleer

|Mar 06, 2021
Preclinical Models in Prostate Cancer: Resistance to AR Targeting Therapies in Prostate Cancer.

Wout Devlies, Florian Handle, Gaëtan Devos

Pageof 2

Frequent Collaborators

8 joint publications

Steven Joniau

4 joint publications

Alexander Giesen

4 joint publications

Wouter Everaerts

3 joint publications

Christophe M Deroose